Platelet-to-albumin ratio is a potential biomarker for predicting diabetic nephropathy in patients with type 2 diabetes

Author:

Cao Shi-Lu12ORCID,Zhang Guo-Qing12,Li Jing3,Bao Li12,Lan Xiao-Mei45,Jin Quan-Peng6,Luo Hong-Yan12,E Jing127,Li Bo125,Ma Danna127,Bao Xi12,Zheng Ya-Li12ORCID

Affiliation:

1. Department of Nephrology, Ningxia Medical University Affifiliated People's Hospital of Autonomous Region of Ningxia, Yinchuan, Ningxia, 750004, China

2. The Third Clinical Medical College of Ningxia Medical University, Yinchuan, Ningxia, 750004, China

3. Department of Pathology, Ningxia Medical University Affiliated People's Hospital of Autonomous Region of Ningxia, Yinchuan, Ningxia, 750004, China

4. Department of Geriatrics, Ningxia Medical University Affiliated People's Hospital of Autonomous Region of Ningxia, Yinchuan, Ningxia, 750004, China

5. Dialysis Department of Nephrology Hospital, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710000, China

6. Department of Endocrinology, Ningxia Medical University Affiliated People's Hospital of Autonomous Region of Ningxia, Yinchuan, Ningxia, 750004, China

7. Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710000, China

Abstract

Aim: To evaluate whether platelet-to-albumin ratio (PAR) can predict diabetic nephropathy (DN) in type 2 diabetes mellitus (T2DM). Materials & methods: A total of 140 patients with T2DM and 40 healthy individuals were enrolled retrospectively. T2DM patients were divided into three groups based on the urinary albumin-to-creatinine ratio, PAR was compared and receiver operating characteristic curve was constructed to evaluate the predictive value of PAR in DN in T2DM. Results: There was a significant increase of PAR in DN among T2DM patients and PAR was positively correlated with serum creatinine, retinol-conjugated protein and β2-microglobulin. Moreover, PAR was a risk factor for DN in T2DM patients, which predicted DN in T2DM with high sensitivity and specificity. Conclusion: PAR can be a potential candidate to predict DN in T2DM.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Ningxia Province

Publisher

Future Medicine Ltd

Subject

Biochemistry (medical),Clinical Biochemistry,Drug Discovery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3